US court opens debate on controversial rule to limit size of patent applications
This article was originally published in RAJ Devices
A US court decision has reopened the debate surrounding four controversial rules issued by the Patent and Trademark Office in 2007 that seek to limit the size of patent applications1.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.